LONDON – Therismos, one of the UK’s largest distributors of unlicensed medicines and subsidiary of leading European cannabis company, Cannaray Limited, today announced an exclusive partnership with Canopy Growth Corporation (“Canopy Growth”), a leading Global Cannabis Company. Therismos has been appointed the sole distributor in the UK and Channel islands of Canopy Growth’s Spectrum Therapeutics medical cannabis products, to provide continued supply of these essential medicines to patients and healthcare professionals.
The partnership is expected to address the challenges of a complex regulatory landscape in the UK regarding cannabis products for medicinal purposes (CBPM). Therismos has established expertise in CBPM distribution through its existing networks and relationship to the wider Cannaray Limited Group, making them the ideal partner to ensure seamless supply of CBPM to patients in need.
“We are excited to partner with Therismos and Cannaray Limited, who have a strong reputation for delivering medical cannabis products and services to patients and healthcare professionals in the UK,” said Paul Steckler, Managing Director, International Markets, at Canopy Growth. “This partnership allows us to continue providing a seamless service and our high-quality Spectrum Therapeutics products to patients in the UK and Channel Islands via Therismos’ distribution networks.”
“We are delighted to partner with Canopy Growth and to have the opportunity to bring their range of Spectrum Therapeutics medical cannabis products to patients in the UK,” said Richard Lunney, Managing Director of Therismos. “Our expertise in distribution of medical cannabis products and other unlicensed medicines, combined with Canopy Growth’s commitment to patient access, makes this a powerful partnership.”
About Cannaray Limited
Cannaray Limited is a leading European cannabis company spanning both Medical Cannabis and CBD wellness brands, headquartered in London, UK.
Therismos is the company’s medical division, which imports and distributes cannabis-based products for medical use (CBPM) across Europe. Its strategy is to become the leading European full-service provider of medicinal cannabis through innovative product solutions, valuable partnerships with strategic allies, and collaboration with world-class scientists and medical practitioners. For more information visit therismospharma.com.
Cannaray CBD is the company’s flagship CBD wellness brand – founded to make CBD easy and accessible for millions of new people. The brand is sold online at cannaraycbd.com, Amazon and eBay, and over 1500 retail outlets across the UK including Tesco, Holland & Barrett, Superdrug, ASDA, Waitrose, Morrisons and Harrods. Cannaray was the first CBD brand to invest in major brand advertising in the UK. For the last 2 years, Cannaray has been the largest CBD advertiser in the UK, with a national TV and outdoor poster campaign featuring Brand Ambassador and UK TV Presenter Claudia Winkleman, who encourages people to ‘Join the CBD Revolution’.
About Canopy Growth
Canopy Growth is a leading North American cannabis and CPG company dedicated to unleashing the power of cannabis to improve lives. Through an unwavering commitment to our consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Doja, 7ACRES, Tweed, and Deep Space. Our CPG portfolio features sugar-free sports hydration brand BioSteel, targeted 24-hour skincare and wellness solutions from This Works, gourmet wellness products by Martha Stewart CBD, and category defining vaporizer technology made in Germany by Storz & Bickel. Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through its rights to Acreage Holdings, Inc. a vertically integrated multi-state cannabis operator with principal operations in densely populated states across the Northeast, as well as Wana Brands, a leading cannabis edible brand in North America, and Jetty Extracts, a California-based producer of high-quality cannabis extracts and pioneer of clean vape technology. Beyond our world-class products, Canopy Growth is leading the industry forward through a commitment to social equity, responsible use, and community reinvestment—pioneering a future where cannabis is understood and welcomed for its potential to help achieve greater well-being and life enhancement. For more information visit www.canopygrowth.com.
